Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A Review.

Li W, Garcia D, Cornell RF, Gailani D, Laubach J, Maglio ME, Richardson PG, Moslehi J
JAMA Oncol. 2017 3 (7): 980-988

PMID: 27632640 · DOI:10.1001/jamaoncol.2016.3350

MeSH Terms (11)

Antineoplastic Agents Cardiovascular Diseases Humans Immunologic Factors Lenalidomide Multiple Myeloma Proteasome Inhibitors Risk Factors Thalidomide Thromboembolism Thrombosis

Connections (1)

This publication is referenced by other Labnodes entities: